Xylem (XYL) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/1/2026
- Wall St futures gain as AI, consulting stocks offset bond-market jitters
- Oil prices rise 2% as China suspends fuel exports
- Amazon and these four U.S. stocks are latest additions to Goldman’s flagship list
- Elevated equity positioning, leverage could challenge stocks in Q4: JPMorgan
- These 5 AI chip stocks are must-own into Q4, BofA says
- Zimbabwe helicopter crash kills six, government spokesperson says
- Apple's iOS 27 is blocking Trade Desk ads on Safari, analyst says
- S&P 500 dips, Nasdaq higher after data shows moderate inflation rise
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Mattel names Roger Lynch as chairman and CEO, replacing Ynon Kreiz
Wedbush Raises Price Target on Xylem (XYL) to $43 Following 1Q Beat
May 4, 2016 8:16 AM EDTWedbush reiterated a Neutral rating on Xylem (NYSE: XYL), and raised the price target to $43.00 (from $41.00), following the company's 1Q earnings report. Adjusted EPS was $0.35 vs. consensus estimates of $0.34. The upside was attributable to slightly better revenues and adjusted operating margins, largely in Water... More
